Document is current
Any future updates will be listed below
-
Authors
Yalçın, Belgin http://orcid.org/0000-0001-9689-9062
Pomrenze, Matthew B. http://orcid.org/0000-0002-9032-5911
Malacon, Karen
Drexler, Richard
Rogers, Abigail E.
Shamardani, Kiarash http://orcid.org/0000-0002-2548-705X
Chau, Isabelle J. http://orcid.org/0000-0003-3733-4760
Taylor, Kathryn R. http://orcid.org/0000-0002-5110-8703
Ni, Lijun
Contreras-Esquivel, Daniel
Malenka, Robert C. http://orcid.org/0000-0002-5428-5211
Monje, Michelle http://orcid.org/0000-0002-3547-237X
- License Information
-
More Information
Article History
Received: 27 January 2023
Accepted: 7 May 2024
First Online: 5 June 2024
Competing interests
: R.C.M. is now on leave from Stanford, functioning as the Chief Scientific Officer at Bayshore Global Management. He is on the scientific advisory boards of MapLight Therapeutics, MindMed, Bright Minds Biosciences and Aelis Farma. M.M. holds equity in MapLight Therapeutics and CARGO Biosciences. The remaining authors declare no competing interests.
